Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Amir Yarahmadi, Romoye Sohan, Brenna McAllister & Leslie A. Caromile. (2022) Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target. Molecular & Cellular Oncology 9:1.
Read now
Read now
Margaritis Avgeris & Andreas Scorilas. (2016) Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies. Expert Opinion on Therapeutic Targets 20:7, pages 801-818.
Read now
Read now
Vittore Cereda, Vincenzo Formica, Antonello Menghi, Stefania Pellicori & Mario Roselli. (2015) Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges. Expert Opinion on Investigational Drugs 24:7, pages 929-947.
Read now
Read now
Articles from other publishers (15)
Ambra Giannetti, Barbara Adinolfi & Sara Tombelli. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy
21
50
.
Giovanni Maria Iannantuono, Francesco Torino, Roberto Rosenfeld, Simona Guerriero, Manuela Carlucci, Stefano Sganga, Barbara Capotondi, Silvia Riondino & Mario Roselli. (2022) The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences 23:15, pages 8535.
Crossref
Crossref
Feyisola P. Olatunji, Emily A. Savoy, Mylan Panteah, Nooshin Mesbahi, Armina Abbasi, Cresencia M. Talley, Christine L. Lovingier, Leslie A. Caromile & Clifford E. Berkman. (2021) Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer Cells. Bioconjugate Chemistry 32:11, pages 2386-2396.
Crossref
Crossref
Tapan Behl, Aditi Sharma, Lalit Sharma, Aayush Sehgal, Gokhan Zengin, Roxana Brata, Ovidiu Fratila & Simona Bungau. (2020) Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives. Biomedicines 8:12, pages 571.
Crossref
Crossref
Yi Ning, Jue Hu & Fangguo Lu. (2020) Aptamers used for biosensors and targeted therapy. Biomedicine & Pharmacotherapy 132, pages 110902.
Crossref
Crossref
Vinoth-Kumar Lakshmanan, Shreesh Ojha & Young Do Jung. (2020) A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancer. Computers in Biology and Medicine 126, pages 104020.
Crossref
Crossref
Edgars Endzeliņš, Vita Melne, Zane Kalniņa, Vilnis Lietuvietis, Una Riekstiņa, Alicia Llorente & Aija Linē. (2016) Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review. Molecular Cancer 15:1.
Crossref
Crossref
Jacob Farnebo, Agnes Wadelius, Per Sandström, Sten Nilsson, Hans Jacobsson, Lennart Blomqvist & Anders Ullén. (2016) Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT. Medicine 95:31, pages e4308.
Crossref
Crossref
Davies Adeloye, Rotimi Adedeji David, Adewale Victor Aderemi, Alexander Iseolorunkanmi, Ayo Oyedokun, Emeka E. J. Iweala, Nicholas Omoregbe & Charles K. Ayo. (2016) An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis. PLOS ONE 11:4, pages e0153496.
Crossref
Crossref
Yukihiro Nishikawa, Daisuke Okuzaki, Kohshiro Fukushima, Satomi Mukai, Shouichi Ohno, Yuki Ozaki, Norikazu Yabuta & Hiroshi Nojima. (2015) Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells. PLOS ONE 10:7, pages e0134137.
Crossref
Crossref
Irene Forno, Stefano Ferrero, Maria Veronica Russo, Giacomo Gazzano, Sara Giangiobbe, Emanuele Montanari, Alberto Del Nero, Bernardo Rocco, Giancarlo Albo, Lucia R. Languino, Dario C. Altieri, Valentina Vaira & Silvano Bosari. (2015) Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression. PLOS ONE 10:6, pages e0130060.
Crossref
Crossref
Tiphaine Belleville, Gaëlle Noé, Olivier Huillard, Audrey Thomas-Schoemann, Michel Vidal, François Goldwasser, Jerome Alexandre & Benoit Blanchet. (2015) A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancer. Journal of Chromatography B 989, pages 86-90.
Crossref
Crossref
Vittorio de Franciscis. (2014) A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer. Molecular Therapy 22:11, pages 1886-1888.
Crossref
Crossref
Justin P Dassie, Luiza I Hernandez, Gregory S Thomas, Matthew E Long, William M Rockey, Craig A Howell, Yani Chen, Frank J Hernandez, Xiu Ying Liu, Mary E Wilson, Lee-Ann Allen, Daniel A Vaena, David K Meyerholz & Paloma H Giangrande. (2014) Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen. Molecular Therapy 22:11, pages 1910-1922.
Crossref
Crossref
Joo Yong LeeDong Hyuk KangDoo Yong ChungJong Kyou KwonHyungmin LeeNam Hoon ChoYoung Deuk ChoiSung Joon HongKang Su Cho. (2014) Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer. The World Journal of Men's Health 32:3, pages 167.
Crossref
Crossref